Home > Companies > Doha Drug Store

Doha Drug Store

Doha Drug Store, one of Qatar’s premier Trading Companies, represents a list of 46 exclusive agencies in the Consumer goods and Pharmaceutical (Generic & Research) Industries. Founded in 1960 by Nasser Bin Khalid & Ali Bin Ali, as a Pharmaceutical Trading Company, the firm has since grown into one of Qatar’s major fast moving consumer goods (FMCG) suppliers, which fully operates its own warehousing, distribution and retail outlets, bringing timely products and services to the customer. Doha Drug Store has a proud heritage of servicing Qatar’s consumer market. Its products are sourced from worldwide locations, which stretch across four continents. Having formed partnering relationships with well-established firms in their respective fields of manufacturing and supply, Doha Drug Store is committed to delivering quality to its valued customers.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

24th World Congress On Pharmaceutical Research and Drug Discovery

Generic drugs and quality control

7th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems

Pharma Manufacturing And Automation

3rd International Pharmaceutical Conference and Expo

World Drug Safety Congress Europe

Related News

YELLOWDOG ACCELERATES DRUG DISCOVERY FROM ONE YEAR TO LESS THAN ONE DAY WITH A 162,120 CORE SUPERCOMPUTER, ON-DEMAND

Prnewswire | September 21, 2020

In drug discovery, as with many of the life sciences, data is key. The size of a dataset and the quality of the analyses has a powerful influence on the success of a given drug development programme. There is great potential for the cloud to aid drug discovery, as it offers companies the ability to dynamically scale their research and analyse more data than they would with their on-premise infrastructure. OMass Therapeutics saw an opportunity to accelerate their virtual screening capabilities by...

PHARMA TECH

FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION TO JELIKALITE

JelikaLite Corp | January 07, 2022

JelikaLite Corp, a medical technology company, announced that the U.S. Food and Drug Administration has granted the Breakthrough Device Designation to its Cognilum System for the reduction of symptoms of moderate to severe autism spectrum disorder in pediatric patients who are 2 to 6 years of age. The FDA’s Breakthrough Device Program recognizes medical devices that meet the criteria and hold the potential for more effective treatment or diagnosis of life-threatening or irre...

KIMERA® LABS FILES FIRST FDA INVESTIGATIONAL NEW DRUG (IND) APPLICATION USING XOGLO® FOR TREATMENT OF ARDS SECONDARY TO COVID-19

Prnewswire | August 18, 2020

Kimera® Labs Inc, a privately held clinical stage biotechnology company, announces the filing of an extended FDA Investigational New Drug (IND) application to study the treatment of COVID-19 related inflammatory disease using Kimera's first-in-class XoGlo® isolated placental mesenchymal stem cell-based exosomes. Founded in 2012, Kimera® generated the first publicly available isolated exosome product and has treated over 35,000 thousand patients for a variety of investigatio...

PHARMACY MARKET

BUSHU PHARMA'S PARTNERSHIP WITH SUZUKEN GROUP INCREASES SPECIALTY PHARMACEUTICAL SERVICES

Bushu Pharmaceuticals Ltd. | April 28, 2021

Bushu Pharmaceuticals Ltd. has entered into a business partnership arrangement with Suzuken Co., Ltd. to provide specialty pharmaceutical producers looking to enter the Japanese market with extensive support for new product releases. In recent years, the market has seen an increase in the number of innovative specialty pharmaceuticals, such as biopharmaceuticals, regenerative medicines, and orphan drugs for rare diseases, that require strict temperature, inventory, and security co...